Show simple item record

URINARY-EXCRETION OF SIALIC-ACID IN PATIENTS WITH SUPERFICIAL BLADDER-TUMORS

dc.contributor.authorEROSENCI, A
dc.contributor.authorUYGUR, C
dc.contributor.authorKONUKOGLU, D
dc.contributor.authorATAUS, S
dc.contributor.authorDIRICAN, A
dc.contributor.authorAKCAY, T
dc.date.accessioned2021-03-04T08:10:53Z
dc.date.available2021-03-04T08:10:53Z
dc.identifier.citationAKCAY T., KONUKOGLU D., EROSENCI A., ATAUS S., DIRICAN A., UYGUR C., "URINARY-EXCRETION OF SIALIC-ACID IN PATIENTS WITH SUPERFICIAL BLADDER-TUMORS", CANCER LETTERS, cilt.78, ss.7-9, 1994
dc.identifier.issn0304-3835
dc.identifier.othervv_1032021
dc.identifier.otherav_61ffb6d3-d89b-4510-9aa9-8b6456c37955
dc.identifier.urihttp://hdl.handle.net/20.500.12627/68267
dc.identifier.urihttps://doi.org/10.1016/0304-3835(94)90024-8
dc.description.abstractUrinary total sialic acid/creatinine (TSA/Cr) ratio was determined in 73 patients with superficial bladder tumors and 34 healthy volunteers. The mean TSA/Cr value in the tumor group was higher than the control group (P < 0.001) and this difference was significant. Comparing the urinary TSA/Cr ratio of T-1, T-a, grade I-II, grade III, single, multiple, primary and recurrent tumors, with the control group revealed significant results (P < 0.001). Therefore the urinary TSA/Cr ratio determination in the follow-up of these patients may be used as a non-invasive procedure.
dc.language.isoeng
dc.subjectOnkoloji
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleURINARY-EXCRETION OF SIALIC-ACID IN PATIENTS WITH SUPERFICIAL BLADDER-TUMORS
dc.typeMakale
dc.relation.journalCANCER LETTERS
dc.contributor.department, ,
dc.identifier.volume78
dc.identifier.startpage7
dc.identifier.endpage9
dc.contributor.firstauthorID115176


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record